Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08 Oktober 2024 - 5:08AM
Business Wire
Incyte (Nasdaq:INCY) today announced that it granted restricted
stock unit awards (RSUs) representing an aggregate of 22,107 shares
of the Company’s common stock to 26 new employees. The awards were
made under the Company’s 2024 Inducement Stock Incentive Plan, with
a grant date and vesting commencement date of October 1, 2024, and
were approved by the compensation committee of the Company’s board
of directors as an inducement material to the new employees
entering into employment with the Company in accordance with Nasdaq
Listing Rule 5635(c)(4).
Each RSU vests as to 25% of the shares subject to the RSU on
each of the first four anniversaries of the vesting commencement
date, subject to the employee's continued service with the Company
on each such date.
About Incyte
A global biopharmaceutical company on a mission to Solve On.,
Incyte follows the science to find solutions for patients with
unmet medical needs. Through the discovery, development and
commercialization of proprietary therapeutics, Incyte has
established a portfolio of first-in-class medicines for patients
and a strong pipeline of products in Oncology and Inflammation
& Autoimmunity. Headquartered in Wilmington, Delaware, Incyte
has operations in North America, Europe and Asia.
For additional information on Incyte, please visit Incyte.com or
follow us on social media: LinkedIn, X, Instagram, Facebook,
YouTube.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241007579570/en/
Media media@incyte.com
Investors ir@incyte.com
Incyte (NASDAQ:INCY)
Historical Stock Chart
Von Okt 2024 bis Nov 2024
Incyte (NASDAQ:INCY)
Historical Stock Chart
Von Nov 2023 bis Nov 2024